Guideline Update: Non-Invasive Tests for Hepatic Fibrosis and Steatosis-NILDA of Hepatic Fibrosis and Steatosis

Video Transcription

Video Summary

Dr. Richard Sterling, a leading expert in Hepatology, discussed updated ASLD guidelines on liver disease assessments. The guidelines focus on non-invasive blood-based and imaging-based tests to evaluate fibrosis and steatosis, offering alternatives to invasive liver biopsies. The guidelines recommend starting with simple blood-based tests like APRE and FIB4 before considering more complex options. Clinicians are advised to incorporate non-invasive tests into practice for patients with chronic liver diseases such as viral hepatitis or MASL. The guidelines provide an algorithm to aid clinicians in identifying significant and advanced fibrosis and recommend close monitoring for patients with borderline results. Additional research is needed in marginalized populations and primary care settings to further advance non-invasive liver disease assessments.<br /><br /><a href="https://www.aasld.org/practice-guidelines/noninvasive-liver-disease-assessment" title="Noninvasive Liver Disease Assessment Guidelines" target="_blank" rel="noopener">CLICK HERE</a> to access these guidelines.

Keywords

Hepatology

non-invasive tests

liver disease

fibrosis assessment

ASLD guidelines